why is my tirzepatide injection site red Reaction: 6 Treatment Options & More why is my tirzepatide red

Standard FDA-approved dosing escalation The FDA-approved tirzepatide dosing schedule, used in the SURMOUNT and SURPASS clinical trials, follows this pattern: Weeks 1 to 4: 2.5 mg once weekly (starting dose) Weeks 5 to 8: 5 mg once weekly Weeks 9 to 12: 7.5 mg once weekly (optional increase) Weeks 13 to 16: 10 mg once weekly (optional increase) Weeks 17 to 20: 12.5 mg once weekly (optional increase) Week 21 and beyond: 15 mg once weekly (maximum dose) Each dose increase happens after a minimum of four weeks at the current dose

Actual selection of meals in the plan is subject to change

There are no reports that administering Mounjaro in the morning or at night affects its effectiveness or increases the chance of side effects

A gradual approach is more sustainable